The research aim is to develop an intelligent agent for cybersecurity systems capable of detecting abnormal user behavior ...
Porter Capital Corporation, a leading provider of working capital solutions, announced the successful funding of a $2 million ...
S&P Global Inc. is rated a Buy with strong Q3 earnings, robust recurring revenue, and strategic acquisitions. Learn more ...
Integration boosts Grid AI’s deployment capacity as AI data-center power demand approaches 50 GW, growing by over 165% ...
The Portage Fire Department said about 90 of the 100 trusses that were being installed on the new Columbia County building collapsed. Two workers had to be rescued after part of the framework at the ...
Focal therapy (FT) is a potential treatment option for limited-volume clinically-significant prostate cancer (csPCa). However, despite rigorous selection, approximately 20% of patients experience ...
Abstract: Single-cell RNA sequencing (scRNA-seq) technology offers unprecedented opportunities for inferring gene regulatory networks (GRNs) at the genome level. However, scRNA-seq data is highly ...
Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the main causes of cancer-related mortality.
WASHINGTON, Oct 20 (Reuters) - The Federal Reserve will go into a policy meeting next week with its view of the economy obscured by a U.S. government shutdown that has suspended the release of key ...
After 5 years, Kisqali ® plus endocrine therapy consistently shows significant and clinically meaningful benefit in invasive disease-free survival 1 Kisqali remains the only CDK4/6 inhibitor ...
Positive opinion based on results of Phase 3 C-POST trial that show Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results